Randomized Controlled Trial of Sequential Intravenous (i.v.) and Oral Moxifloxacin Compared with Sequential i.v. and Oral Co-Amoxiclav with or without Clarithromycin in Patients with Community-Acquired Pneumonia Requiring Initial Parenteral Treatment

The objective of the present trial was to compare the efficacy, safety, and tolerability of moxifloxacin (400 mg) given intravenously (i.v.) once daily followed by oral moxifloxacin (400 mg) for 7 to 14 days with the efficacy, safety, and tolerability of co-amoxiclav (1.2 g) administered by i.v. inf...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Finch, R., Schürmann, D., Collins, O., Kubin, R., McGivern, J., Bobbaers, H., Izquierdo, J. L., Nikolaides, P., Ogundare, F., Raz, R., Zuck, P., Hoeffken, G.
Format: Artigo
Sprog:Inglês
Udgivet: American Society for Microbiology (ASM) 2002
Fag:
Clinical Therapeutics
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC127227/
https://ncbi.nlm.nih.gov/pubmed/12019085
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.46.6.1746-1754.2002
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker